Functional decline is a key concern in older adults with type 2 diabetes mellitus (T2DM), particularly as treatment strategies may influence independence and long-term care needs. A database-based observational study published in Diabetology examined how glycemic management and medication use relate to the severity of functional impairment in elderly individuals with T2DM.

The analysis used data from the Japanese National Health Insurance Database between 2017 and 2024 and included 11,411 adults aged 65 years or older who had undergone Long-Term Care Insurance (LTC) evaluations. Functional status was categorized into three levels based on independence: Group A (non-mild impairment), Group B (moderate impairment), and Group C (severe impairment). Associations between glycemic parameters, medication use, and impairment severity were assessed.

Functional impairment was more pronounced in individuals with T2DM compared with those without diabetes. Within the T2DM group, lower glycated hemoglobin (HbA1c) levels were observed in those with more severe impairment (odds ratio [OR]: 0.78; p<0.001). In contrast, the use of antidiabetic medications with a higher risk of severe hypoglycemia showed higher odds of greater impairment severity (Group A vs B/C: OR 1.42; p<0.001; Group C vs A/B: OR 1.90; p<0.001). The frequency of high-risk drug use increased across worsening impairment categories.

These findings indicate that treatment patterns and glycemic levels differ across functional impairment severity in older adults with T2DM, highlighting considerations for individualized management in this population.